tirzepatide monthly weight loss 3 months vs. 6 months on average weight loss on tirzepatide

There are also some rare but serious risks, including pancreatitis, gallbladder issues, and potential thyroid tumors

Who Should Consider GLP-1 Antagonists

Conxita Jacobs-Cach, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Reference: Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction-associated steatotic liver disease: Post hoc analysis of three randomised controlled trials - ( Source-Medindia

Schedule an in-person or telehealth visit to get started